Author:
Mungati More,Mhangara Mutsa,Gonese Elizabeth,Mugurungi Owen,Dzangare Janet,Ngwende Stella,Musasa Patience,Wellington Maureen,Shambira Gerald,Apollo Tsitsilina,Yang Chunfu,DeVos Joshua,Sabatier Jennifer,Kilmarx Peter,Chakanyuka-Musanhu Christine,Tshimanga Mufuta
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference14 articles.
1. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995;267(5197):483–9.
2. Clavel F, Hance AJ. HIV drug resistance. N Engl J Med. 2004;350:1023–35. doi: 10.1056/NEJM200406243502621 .
3. WHO. WHO HIV drug resistance report 2012. Geneva: World Health Organisation; 2012.
4. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organisation’s global strategy for prevention and assessment on HIV drug resistance. Antivir Ther. 2008;13(2):1–13.
5. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osiboqun A, Siqaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vuqt M, de Wit TF. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis. 2011;11:750–9. doi: 10.1016/S1473-3099(11)70149-9 .